Abstract
A major goal in gene therapy is to develop efficient gene transfer protocols that allow tissue-specific, long-term and tightly regulated expression of the desired transgene. This objective is becoming more attainable through the co-evolution of gene transfer vectors and regulation systems. The ideal vector should efficiently transduce non-dividing cells with minimal toxicity, thus endowing the system with persistent transgene expression. The helper-dependent adenovirus vectors meet these requirements, as demonstrated in various studies in the literature. The most promising regulation system is the tet-on system, which has low basal transcriptional activity and high inducibility. To explore the regulated transgene expression in the context of a helper-dependent vector, we constructed the HD-TET-IFN vector, containing the mIFNα gene under the control of the tetracycline inducible transactivator rtTA2s-S2. Mice injected with HD-TET-IFN showed high levels of serum mIFNα only upon transcriptional activation. The transgene expression was reinducible to the same high level up to 3 months p.i., and the amount of expressed cytokine could be regulated by dosing doxycycline. Transcriptional activation of mIFNα induced by doxycycline resulted in prolonged survival and reduced liver damage in HD-TET-IFN-injected mice challenged with a lethal dose of coronavirus. Activation of antiviral genes mediated by doxycycline-dependent mIFNα expression was also observed at low HD-TET-IFN doses. The possibility of controlling gene expression by the combination of HD vectors and the latest tet-on transactivator also holds promise for studying gene function in other animal models.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
References
Russell WC . Update on adenovirus and its vectors J Gen Virol 2000 81: 2573–2604
Lusky M et al. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted J Virol 1998 72: 2022–2032
Schiedner G et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity (published erratum appears in Nat Genet 1998; 18: 298) Nat Genet 1998 18: 180–183
Thomas CE et al. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases Proc Natl Acad Sci USA 2000 97: 7482–7487
Maione D et al. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector Hum Gene Ther 2000 11: 859–868
Parks RJ et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal Proc Natl Acad Sci USA 1996 93: 13565–13570
Kochanek S et al. High-capacity adenoviral vectors for gene transfer and somatic gene therapy Hum Gene Ther 1999 10: 2451–2459
Corti O et al. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease Proc Natl Acad Sci USA 1999 96: 12120–12125
Burcin MM et al. Adenovirus-mediated regulable target gene expression in vivo Proc Natl Acad Sci USA 1999 96: 355–360
Baron U, Bujard H . Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances Meth Enzymol 2000 327: 401–421
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc Natl Acad Sci USA 1992 89: 5547–5551
Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells Science 1995 268: 1766–1769
Kafri T, van Praag H, Gage FH, Verma IM . Lentiviral vectors: regulated gene expression Mol Ther 2000 1: 516–521
Pitzer C et al. In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system Cancer Gene Ther 1999 6: 139–146
Rizzuto G et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation Proc Natl Acad Sci USA 1999 96: 6417–6422
Urlinger S et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity Proc Natl Acad Sci USA 2000 97: 7963–7968
Eto T, Takahashi H . Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon Nat Med 1999 5: 577–581
Aurisicchio L et al. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis J Virol 2000 74: 4816–4823
Protzer U et al. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection Proc Natl Acad Sci USA 1999 96: 10818–10823
Carlow DA, Teh SJ, Teh HS . Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases J Immunol 1998 161: 2348–2355
Sandig V et al. Optimization of the helper-dependent adenovirus system for production and potency in vivo Proc Natl Acad Sci USA 2000 97: 1002–1007
Kistner A et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice Proc Natl Acad Sci USA 1996 93: 10933–10938
Kato Y et al. Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus type 2 Dig Dis Sci 1986 31: 177–180
Minagawa H, Takenaka A, Mohri S, Mori R . Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection Antiviral Res 1987 8: 85–95
Schowalter DB et al. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice J Virol 1999 73: 4755–4766
Hitt MM, Addison CL, Grahm FL . Human adenovirus vectors for gene transfer into mammalian cells Adv Pharmacol 1997 40: 137–206
Rivera VM et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer Proc Natl Acad Sci USA 1999 96: 8657–8662
Rivera VM et al. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer
Pastore L et al. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors Hum Gene Ther 1999 10: 1773–1781
Morral N et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons Proc Natl Acad Sci USA 1999 96: 12816–12821
Acknowledgements
We thank S Germoni and M Aquilina for animal care, C Toniatti for critically reading of the manuscript and Domenico Lazzaro for the immunohistochemistry. We also thank J Clench for editorial assistance and G Bifolchetti for graphics.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aurisicchio, L., Bujard, H., Hillen, W. et al. Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector. Gene Ther 8, 1817–1825 (2001). https://doi.org/10.1038/sj.gt.3301596
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.gt.3301596
Keywords
This article is cited by
-
Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer
BMC Cancer (2006)
-
Liver-specific expression of interferon γ following adenoviral gene transfer controls hepatitis B virus replication in mice
Gene Therapy (2005)
-
Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR
Gene Therapy (2004)
-
Gene therapy progress and prospects: transcription regulatory systems
Gene Therapy (2004)
-
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system
Gene Therapy (2002)


